The application of adjuvant radiotherapy after radical nephroureterectomy in the treatment of upper tract urothelial carcinoma
10.3760/cma.j.cn112330-20200309-00169
- VernacularTitle:术后辅助放疗在上尿路尿路上皮癌治疗中的应用现状
- Author:
Kunlin YANG
1
;
Xiaoying LI
;
Xuesong LI
;
Liqun ZHOU
Author Information
1. 北京大学第一医院泌尿外科 北京大学泌尿外科研究所 国家泌尿男生殖系肿瘤研究中心，北京 100034
- From:
Chinese Journal of Urology
2020;41(5):394-396
- CountryChina
- Language:Chinese
-
Abstract:
Urothelial carcinoma (UC) is the second most commonly diagnosed genitourinary tumor, and upper tract urothelial carcinoma (UTUC) accounts for 5% of UC in USA. It may be more in Asia. Senventy-eight percent of UTUC may be invasive when diagnosed. The radical nephroureterectomy (RNU) with bladder cuff is the golden standard treatment. In recent years, as the development of radiotherapy, adjuvant radiotherapy (ART) after RNU has been used to treat UTUC patients, but its efficacy is still a controversy. We did this review focusing on ART’s efficacy after RNU to guide and help the clinical practice.
